No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Approval Alert: Formycon/Fresenius’ Ustekinumab Biosimilar Approved in US and Europe
On 27 September 2024, Formycon and Fresenius Kabi announced that Otulfi®/FYB202, biosimilar to Janssen’s Stelara® (ustekinumab), has received approval from both the European Commission and the US FDA. The European approval is for moderately to severely active Crohn’s...